Obesity-driven chronic inflammation and impaired fibrinolysis appear to be major effector
mechanisms of thrombosis in obesity. The proinflammatory and hypofibrinolytic effects of …

Being overweight or obese, as measured with body-mass index or central adiposity (waist
circumference), and the trajectory of body-mass index over the life course have been …

Obesity is a pandemic and a serious global health concern. Obesity is a risk factor for
multiple conditions and contributes to multi-morbidities, resulting in increased health costs …

The proportion of patients defined as obese continues to grow in many westernized nations,
particularly the United States (USA). This trend has shifted the perioperative management of …

The increasing burden of obesity plays an essential role in increased cardiovascular
morbidity and mortality. The effects of obesity on the cardiovascular system have also been …

Associations between biomarkers and noninvasive measures of early atherosclerosis in
children continue to emerge and several biomarkers appear to be promising. At present …

Thrombosis is frequently diagnosed as a first symptom in tumor patients and the clinical
management of hypercoagulability in cancer patients remains challenging due to …

The growth of adipose tissue and its vasculature are tightly associated. Angiogenic factors
have been linked to obesity, yet little is known about their expression during early childhood …

An early activation of coagulation and fibrinolysis occurs during sepsis, leading to the
syndrome of disseminated intravascular coagulation (DIC). Obesity has been demonstrated …

OBJECTIVE In adults with diabetes, in vivo platelet activation is a marker for atherosclerosis
and cardiovascular disease (CVD). This pilot study investigated whether adolescents with …